1 Min Read
Jan 12 (Reuters) - Glaxosmithkline Plc:
* GSK RECEIVES FDA APPROVAL FOR EXPANDED INDICATION FOR FLUARIX® QUADRIVALENT (INFLUENZA VACCINE) FOR PERSONS 6 MONTHS AND OLDER Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.